Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27

Baseline patient and tumor characteristics differentially affected type of death in the MA.17 placebo-controlled letrozole trial where cardiovascular death was not separately identified. The MA.27 trial allowed competing risks analysis of breast cancer (BC), cardiovascular, and other type (OT) of de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Chapman, Judith-Anne W., Shepherd, Lois E., Ingle, James N., Muss, Hyman B., Pritchard, Kathleen I., Gelmon, Karen A., Whelan, Timothy J., Elliott, Catherine, Goss, Paul E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363272/
https://ncbi.nlm.nih.gov/pubmed/27006189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3761-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados